These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 30144998

  • 21. Infliximab Therapy and the Central Nervous Demyelination in Patients with Kawasaki Disease.
    Sagara Y, Muneuchi J, Shimabukuro W, Joo M, Yoshino M, Nakamura R, Yoneda T, Sugitani Y, Watanabe M, Mizushima A, Takahashi Y.
    Pediatr Infect Dis J; 2019 Aug; 38(8):e185-e187. PubMed ID: 31107420
    [Abstract] [Full Text] [Related]

  • 22. Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression.
    Millar K, Manlhiot C, Yeung RS, Somji Z, McCrindle BW.
    Int J Cardiol; 2012 Jan 12; 154(1):9-13. PubMed ID: 20851480
    [Abstract] [Full Text] [Related]

  • 23. Does abciximab promote coronary artery remodeling in patients with Kawasaki disease?
    McCandless RT, Minich LL, Tani LY, Williams RV.
    Am J Cardiol; 2010 Jun 01; 105(11):1625-8. PubMed ID: 20494673
    [Abstract] [Full Text] [Related]

  • 24. Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease.
    Migally K, Braunlin EA, Zhang L, Binstadt BA.
    Pediatr Res; 2018 Jun 01; 83(6):1136-1145. PubMed ID: 29554081
    [Abstract] [Full Text] [Related]

  • 25. Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.
    Matsuoka R, Furuno K, Nanishi E, Onoyama S, Nagata H, Yamamura K, Sugitani Y, Kuraoka A, Mizuno Y, Sagawa K, Honjo S, Hara T, Ohga S.
    J Pediatr; 2020 Dec 01; 227():224-230.e3. PubMed ID: 32810506
    [Abstract] [Full Text] [Related]

  • 26. A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.
    Koyama Y, Miura M, Kobayashi T, Hokosaki T, Suganuma E, Numano F, Furuno K, Shiono J, Ebata R, Fuse S, Fukazawa R, Mitani Y.
    Eur J Pediatr; 2023 Feb 01; 182(2):633-640. PubMed ID: 36434403
    [Abstract] [Full Text] [Related]

  • 27. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec 01; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 28. Plasma exchange and infliximab as a third-line therapy for refractory infantile Kawasaki disease.
    Ansai H, Masuda H, Nakao H, Nishimura N, Kubota M.
    Pediatr Int; 2022 Jan 01; 64(1):e15226. PubMed ID: 35831245
    [Abstract] [Full Text] [Related]

  • 29. The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease.
    Ebato T, Ogata S, Ogihara Y, Fujimoto M, Kitagawa A, Takanashi M, Ishii M.
    J Pediatr; 2017 Dec 01; 191():140-144. PubMed ID: 29173297
    [Abstract] [Full Text] [Related]

  • 30. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
    Paediatr Int Child Health; 2018 Aug 01; 38(3):209-212. PubMed ID: 29768976
    [Abstract] [Full Text] [Related]

  • 31. Risk factors and scores for prediction of coronary artery aneurysms in Kawasaki disease: a European monocentric study.
    La Vecchia A, Stracquadaino R, Mauri L, Baselli LA, Abdallah R, Cucchetti M, Colli AM, Agostoni C, Dellepiane RM.
    BMC Pediatr; 2024 Feb 23; 24(1):139. PubMed ID: 38395821
    [Abstract] [Full Text] [Related]

  • 32. Cost-effectiveness analysis of infliximab for the treatment of Kawasaki disease refractory to the initial treatment: A retrospective cohort study.
    Takura T, Horiuchi S.
    J Cardiol; 2022 Aug 23; 80(2):172-178. PubMed ID: 35341683
    [Abstract] [Full Text] [Related]

  • 33. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    Iio K, Morikawa Y, Miyata K, Kaneko T, Misawa M, Yamagishi H, Miura M.
    J Pediatr; 2022 Jan 23; 240():158-163.e4. PubMed ID: 34461064
    [Abstract] [Full Text] [Related]

  • 34. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.
    Han CL, Zhao SL.
    Med Sci Monit; 2018 Oct 11; 24():7264-7270. PubMed ID: 30307902
    [Abstract] [Full Text] [Related]

  • 35. Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease.
    Tanaka A, Inoue M, Hoshina T, Koga H.
    J Pediatr; 2021 Sep 11; 236():95-100. PubMed ID: 34019881
    [Abstract] [Full Text] [Related]

  • 36. Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease.
    Zhao CN, Du ZD, Gao LL.
    Chin Med J (Engl); 2016 Apr 20; 129(8):922-8. PubMed ID: 27064036
    [Abstract] [Full Text] [Related]

  • 37. Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).
    Tremoulet AH, Jain S, Kim S, Newburger J, Arditi M, Franco A, Best B, Burns JC.
    Contemp Clin Trials; 2016 May 20; 48():70-5. PubMed ID: 27080929
    [Abstract] [Full Text] [Related]

  • 38. Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression.
    Kato T, Miura M, Kobayashi T, Kaneko T, Fukushima N, Suda K, Maeda J, Shimoyama S, Shiono J, Hirono K, Ikeda K, Sato S, Numano F, Mitani Y, Waki K, Ayusawa M, Fukazawa R, Fuse S, Z‐Score Project 2nd Stage Study Group *.
    J Am Heart Assoc; 2023 Feb 07; 12(3):e022417. PubMed ID: 36718857
    [Abstract] [Full Text] [Related]

  • 39. Anakinra Treatment in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysms: A Phase I/IIa Trial.
    Yang J, Jain S, Capparelli EV, Best BM, Son MB, Baker A, Newburger JW, Franco A, Printz BF, He F, Shimizu C, Hoshino S, Bainto E, Moreno E, Pancheri J, Burns JC, Tremoulet AH.
    J Pediatr; 2022 Apr 07; 243():173-180.e8. PubMed ID: 34953816
    [Abstract] [Full Text] [Related]

  • 40. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
    Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J.
    Eur J Pediatr; 2009 Nov 07; 168(11):1315-21. PubMed ID: 19159953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.